From cells to 3D tissues: Creating complex 3D tissue models using CELLINKs technologies

In this presentation, we will discuss how 3D bioprinting technologies enable the fabrication of more reliable tissue models, which have wide application, including the development and validation of the efficacy of pharmaceutical products, screening of drug therapies and understanding of tissue development and oncology processes.

Continue reading “From cells to 3D tissues: Creating complex 3D tissue models using CELLINKs technologies”

Enabling Novel Pharmaceutical Therapies through 3D-Printing

Aprecia continues its leadership position in the pharmaceutical application of 3D-Printing. Aprecia will be launching its two new platforms later this year that will provide additional benefits in early development FIH clinical as well as small and large scale commercial production. In this presentation, Aprecia will discuss the flexibility and precision these platform provide in delivering novel products to the market.

Continue reading “Enabling Novel Pharmaceutical Therapies through 3D-Printing”